Skip to main content

West Pharmaceutical Services Value Stock - Dividend - Research Selection

West pharmaceutical services

ISIN: US9553061055 , WKN: 864330

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Why The Narrative Around West Pharmaceutical Services (WST) Is Shifting After New Valuation Updates

2026-02-08
West Pharmaceutical Services has seen its fair value estimate trimmed slightly, with the price target moving from about US$345.71 to US$338.57 per share as analysts refresh their models around growth and risk. The latest commentary links this shift to somewhat softer revenue growth assumptions and a marginally higher discount rate, which together pull the valuation estimate a bit lower, even as the core story remains under debate. Stay tuned to see how you can keep on top of these evolving...

West Pharmaceutical Services, Inc. (WST): A Bull Case Theory

2026-02-07
We came across a bullish thesis on West Pharmaceutical Services, Inc. on TipRanks™’s YouTube Channel. In this article, we will summarize the bulls’ thesis on WST. West Pharmaceutical Services, Inc.’s share was trading at $271.83 as of January 13th. WST’s trailing and forward P/E were 40.27 and 36.23 respectively according to Yahoo Finance. West Pharmaceutical Services, Inc. […]

West Pharmaceutical Services Unveils “Synchrony S1” Syringe System to Speed Drug Packaging Development

2026-02-07
West Pharmaceutical Services (NYSE:WST) outlined a new approach to prefillable syringe (PFS) packaging development during a webinar hosted by Pharmaceutical Online, framing the offering as a way to reduce development complexity and shorten timelines for drug developers—particularly emerging biotechn

West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity Transcript

2026-02-05
West Pharmaceutical Services, Inc. (WST) Discusses Integrated Prefillable Syringe Systems to Streamline Drug Development and Reduce Complexity February 5,...

West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

2026-02-05
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Top 50 High-Quality Dividend Growth Stocks For February 2026

2026-02-04

Reasons to Add Cooper Companies Stock to Your Portfolio Now

2026-02-03
COO is riding premium MyDay lens momentum and margin expansion plans, but Asia-Pacific softness, tariffs and mix pressures pose near-term risks.

Top 15 High-Growth Dividend Stocks For February 2026

2026-02-01
Top 15 dividend growth stocks for Feb 2026: 1.52% yield, 15.48% 5yr dividend growth & ~27% undervalued.

West Pharmaceutical Services (WST) Valuation Check After Recent Share Price Pressure

2026-01-31
West Pharmaceutical Services (WST) has been drawing attention after recent trading pressure, with the share price down around 16% over the past month and about 18% over the past 3 months. See our latest analysis for West Pharmaceutical Services. That recent selling comes on top of a wider reset, with a 30 day share price return of 16% and a 1 year total shareholder return of 32%, suggesting momentum has been fading despite the latest close at $231.12. If West Pharmaceutical Services has you...

Best Dividend Aristocrats For February 2026

2026-01-31
Dividend Aristocrats lagged the S&P 500 in 2025 but started 2026 strong.